… in the case of cytogenetic or molecular relapse compared with hematological relapse.1 …
the blood or bone marrow of CML patients in molecular remission (RT-PCR–negative) after …

… : 75 days) at the time of the deepest known remission – complete haematological remission,
or complete molecular remission in patients with mutation in NPM1 or fusion genes (KMT2A-…

… In contrast, 11 relapses were seen in the group of 15 patients with persistent PCR-positive
molecular follow-up. In the remaining 10 patients, PCR analysis at different time points …

… Persistence of complete molecular remission in chronic myeloid leukemia after imatinib
discontinuation: Interim analysis of the STIM trial. J Clin Oncol 2009; 27, Abstract no. 7084. …

… been treated with interferon α, we aimed to assess persistence of CMR after discontinuation
of imatinib, and establish the factors that could be associated with CMR persistence. …

… persistence of monoclonally rearranged Ig heavy chain gene fragments, thus excluding …
remission at the molecular level. The monoclonal bands of the cases in apparent true remission …

… t(11;18) was not found in any of the patients with persistent monoclonality. Time and …
remission in 90% of patients, but molecular remission is not accomplished in most cases. Molecular …

… However, although loss of malignant clones by deep sequencing PCR was uniformly noted
in all patients with persistent disease at the time of 19-28z + T cell therapy, we concomitantly …

… those who experienced remission to identify risk factors for persistence. We … -persistent
with ADHD-remitted individuals to examine the effect of remission on functioning, and persistent …

… MRD persistence is associated with persistence of the … inadequate marker of tumor
persistence, and their inclusion … of molecular follow-up in cases without a molecular marker. …